|
FOUNDATION FOR THE DEVELOPMENT OF INTERNAL
MEDICINE IN EUROPE (FDIME) AWARDS NEW FELLOWSHIP IN RENAL PHYSIOLOGY AND
PATHOPHYSIOLOGY
Prof.
Philippe Jaeger, Chairman of the executive committee and Vice President of
FDIME, presented the one-year Fellowship to Maria Haller, M.D., at the European
Masterclass in Renal Physiology and Pathophysiology for the Clinician in London
London,
23, June 2008 – The Foundation for the Development of Internal Medicine in
Europe (FDIME) today announced the recipient of the new Fellowship in Renal
Physiology and Pathophysiology. Supported by an educational grant from
biotechnology company Amgen, the Fellowship was awarded to Dr Maria Haller
from the University of Vienna, Austria, to carry out research in renal
physiology. The research will be conducted at the Institute of Physiology in
Zurich, as well as at the Division of Pharmacoepidemiology at Brigham and
Women’s Hospital, Harvard Medical School, Boston, where Dr Haller will also gain
clinical physiology experience and training.
The
one-year Fellowship was announced in London at the European Masterclass in Renal
Physiology and Pathophysiology for the Clinician by the Chairman of its
executive committee, Professor Philippe Jaeger (UK) who presented the award to
the candidate (see picture above). Of note, the Treasurer of FDIME, Mr Imad
Hatem came all the way from Switzerland to hand over the accompanying check.
“Through
the Fellowship we intend to develop the understanding of diseases of the kidney,
one of the most difficult specialties of internal medicine” commented Prof.
Daniel Sereni, Professor of Medicine at the University of Paris, Head of the
Department of Internal Medicine, Saint-Louis Hospital, Paris and President of
FDIME.
For
reasons which are not currently understood, ninety percent of patients whose
transplanted kidneys have excellent filtration function still experience
potentially life-threatening low levels of phosphate. Dr Haller’s research will
look at the renal transport of phosphate in patients who have had kidney
transplants. It hopes to shed light on the regulation of phosphate transporters
at the molecular level.
“Amgen is
committed to advancing nephrology research and, in collaboration with physicians
and other medical experts, seeks to better understand important aspects of renal
disease to help patients live longer and fuller lives.” said
Dr Willard Dere, International Chief Medical Officer, Amgen. “We are delighted
to partner with FDIME to show our support for research into nephrology and
internal medicine, and would like to congratulate Dr Haller.”
The
Fellowship was judged by an eminent panel taken from the Scientific Committee
of the Masterclass which comprised
Tilman Drueke, Necker Hospital
, Paris, France (Chair);
D. Bichet, Canada;
O. Devuyst, Belgium;
M. Halperin, Canada;
P. Houillier, France; S. Lindgren, Sweden (FDIME representative);
F. Luft, Germany;
C. Wilcox, USA;
and R. Zietse, The Netherlands. “The winner was selected from ten
extremely high quality research project outlines submitted by the next
generation of expert academic physicians in internal medicine and nephrology
from Europe. The judging panel based its decision on scientific quality and
feasibility as well as the potential of the candidate” stated Professor Drüeke
The European Masterclass
of Renal Physiology and Pathophysiology for the Clinician was held at the Royal
College of Physicians in London from June 19th to the 21st,
2008.
The meeting brought
together the next generation of academic physicians in internal medicine and
nephrology from across Europe, and highlighted the significance of renal
physiology in medicine and its application at the bedside. Renal physiology is
an essential part of the education of a clinical nephrologist, in particular
those who ultimately will impart their knowledge to junior doctors in training.
The Masterclass was organised by the Centre for Nephrology and the Department of
Physiology at University College of London (Hampstead Campus); it involved an
international faculty panel of high scientific and didactic expertise and was
supported by an educational grant from Amgen.
|
